Clinical Trial Update: A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

View source ↗

Summary

This update describes a long-term observational study evaluating eteplirsen, golodirsen, and casimersen in routine clinical practice for Duchenne muscular dystr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• AMONDYS 45 (Casimersen)
• EXONDYS 51 (eteplirsen)
• VYONDYS 53 (golodirsen)

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy | Status: ENROLLING_BY_INVITATION